Saturday, December 17, 2005


Hepatitis C Therapy - Annual 25-30% Growth in Use of Health Care Resources among HCV Patients for Hospitalizations, Charges, Hospita



Daily Mail - Rising numbers of people suffering severe liver disease caused by

Annual 25-30% Growth in Use of Health Care Resources among HCV Patients for Hospitalizations, Charges, Hospita
HIV and Hepatitis.com - As individuals with

GlobeImmune Relocates Corporate Headquarters
Pharma Live - LOUISVILLE, Colo., December 15, 2005 /PRNewswire/ -- GlobeImmune, Inc. today announced the relocation of its corporate headquarters to Louisville, Colorado. 1b trial for its second product, GI-5005, a Tarmogen for the treatment of chronic

Hepatitis C Therapy - How to Choose a Doctor



How to Choose a Doctor
Title: How to Choose a Doctor
Category: Doctor's Views
Created: 6/17/2005
Last Editorial Review: 8/9/2005
Japanese Researchers Make Progress
This article is from one of the largest Japanese newspapers. As it shows, researchers in Japan are also working hard to develop a better treatment for HCV. Scientists the world over are doing their best to find a less toxic...
Hepatitis C
Title: Hepatitis C
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 9/17/2005

Hepatitis C Therapy - National HCV Prison Coalition - Hepatitis C Awareness Project


National HCV Prison Coalition - Hepatitis C Awareness Project
The National Hepatitis C Prison Coalition provides support to prison inmates who are suffering from hepatitis C (HCV) and HIV/HCV coinfection.

HIV and HCV - Liver Health Information - The American Liver Foundation
If you have HIV/HCV co-infection, then you have both HIV and HCV. I already know about HCV. What do I need to learn about HIV?

HCV Wireless
Kompakar & HCV Wireless In Partnership To Launch Fixed-Mobile Convergence Alcatel have partnered with HCV Wireless to deliver Fixed Mobile Convergence

DNA microarray analysis of chimpanzee liver during acute resolving
Hepatitis C virus (HCV) poses a worldwide health problem in that the majority of individuals exposed to HCV become chronically infected and are predisposed

Hepatitis C Therapy - [Behavior of Owren's Thrombotest in acute viral hepatitis, viral heaptitis of prolonged duration, acute post-...


[Behavior of Owren's Thrombotest in acute viral hepatitis, viral heaptitis of prolonged duration, acute post-...
No abstract available

Hepatitis C Information
... of Owren's Thrombotest in acute viral hepatitis, viral heaptitis of prolonged duration, acute post-hepatitis atrophy ... Coinfection HIV & Viral Heaptitis: a. guide. December 2003 ...

World J Gastroenterol
... Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. ...

P
... does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B ... treatment of mutant type chronic viral heaptitis B.World J Gastroenterol 2002 ...

Find The Top Weight Loss Site and Recent Blog Posts
Top Weight Loss Sites, Blogs and News. When you're looking for a top weight loss site then you'll find that your Internet search can become very frustrating. ... antibiotics, Weight Loss drugs, Weight Institute of Viral Heaptitis, First Affiliated Hospital, WCUMS, Chengdu 610041 ...

Untitled Document
... There are, however, non-viral heaptitis caused by drugs, alcoholic and toxi elements. ...

Hepatitis C Therapy - Hepatitis B



Hepatitis B
Title: Hepatitis B
Category: Diseases and Conditions
Created: 1/26/2001 11:58:00 AM
Last Editorial Review: 9/21/2005
HCV Vaccine Progress
The development of a HCV vaccine is very exciting, even to patients already infected. Although the vaccine will not help them direcly, it shows definite progress in understanding and outsmarting this virus that is known to be difficult to combat...

Friday, December 16, 2005


Hepatitis C Therapy - A Summary of Chronic Hepatitis C InfectionHepatitis C is a

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.

Hepatitis C Therapy - Infectious Mononucleosis



Infectious Mononucleosis
Title: Infectious Mononucleosis
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 12/14/2005
Pegasys Shown More Effective In Study
Schering and Roche are taking part in dueling press releases. Each claiming their solution is better. Either way, they seem to be splitting hairs regarding effectiveness. There is no clear winner when they keep firing PR salvos back and forth....
Hepatitis B
Title: Hepatitis B
Category: Diseases and Conditions
Created: 1/26/2001 11:58:00 AM
Last Editorial Review: 9/21/2005

Hepatitis C Therapy - Hepatitisactivist.org: Instant Advocacy Initiative


Hepatitisactivist.org: Instant Advocacy Initiative
Hepatitis, Hepatitis C, Hepatitis B, Cirrhosis, and Liver Disease Information Including Hepatitis C and Other Liver Disease Links and Resources.

Hepatitis C Resources and Information
Hepatitis C Resources and Information is a website with up-to-date hepatitis C weblinks, hep C information, HCV defined and undefined, inspiration for people who have hepatitis C and their families and so much more. ... A.K.A. ROSEHEPPER'S HEP C SITE. A happy day is designed ... Hcv Defined/Undefined. Hep C Links. My Story ...

What I Need to Know About Hepatitis C
explains how the hepatitis virus affects the liver, how it is spread, symptoms of infection, and treatment options.

Hep-C Quilt
International Hep-C Quilts. The Hep-C quilts are made up of patches submitted by people from all over the world with Hepatitis C. They are sewn together by me, Marie Stern, in my spare time.

Hepatitis C ... HCV treatments .. Save a life Beat Hepatitis C
Learn how to beat hepatitis c and its symptoms. Beat chronic hep c virus ( HCV) with alternative medicine treatment and herbal supplements including milk thistle, natcell thymus to prevent liver disease. ... medical machine fails to deal with hep c - hcv , and it provides the alternative medicine ... hepatitis c ( hcv ), hepatitis c ( hep c ) treatment, cancer therapy and alternative ...

Thursday, December 15, 2005


Hepatitis C Therapy - Hepatitis C


Hepatitis C
have serious, long-lasting health consequences. What is the infectious agent that causes

THE TREATMENT OF ACUTE
THE TREATMENT OF ACUTE

Hepatitis C - Page 1
and the development of antibody screening tests, the number of newly acquired acute

Hepatitis C liver disease information - Roche UK healthcare

eMedicine - Hepatitis C : Article by Sandeep Mukherjee, MD
have reported a lower response rate to IFN alfa among black patients with chronic

Hepatitis C Therapy - Acute Viral Hepatitis C (PDF)


Acute Viral Hepatitis C (PDF)
... Public Health Surveillance for. Acute Viral Hepatitis C ...

In a Nutshell: Management of Viral Hepatitis C
In a Nutshell: Management of Viral Hepatitis C. Abstract. The hepatitis C virus was first identified in 1989. It causes chronic hepatitis, cirrhosis and hepatocellular carcinoma.

Market Wire: Bayer Receives FDA Approval After Expedited Review for Hepatitis C Viral Load Assay, VERSANT(R) HCV RNA...
... References U.S. Centers for Disease Control and Prevention. Viral hepatitis C: fact sheet ...

Hepatitis C Index
... CDC's National Center for Infectious Diseases. Viral Hepatitis C Fact Sheet, Frequently Asked Questions, Pamphlets ...

Hepatitis C
... Johns Hopkins - Viral Hepatitis C. Source: Johns Hopkins Gastroenterology & Hepatology Resource ... CDC - Viral Hepatitis C. FAQ's, updates, guidelines and recommendations, and resources ...

Hepatitis C Therapy - Hepatitis and Health news and miscellaneous communications


Hepatitis and Health news and miscellaneous communications
mutant type chronic viral heaptitis B. Yang SS, Hsu CT, Hu JT, Lai YC, Wu CH. liver Unit, Cathay General hospital,280 Sec.4,Jen-Ai Rd.,Taipei,Taiwan

Viral hepatitis
ivral hepatitis / vrial hepatitis / viarl hepatitis / virla hepatitis / vira lhepatitis / Viral ehpatitis / Viral hpeatitis / Viral heaptitis / Viral

Observation of lipid profile and lipoproteins in viral hepatitis
VLDL levels were significantly decreased in patients of viral heaptitis (22.13 �8 mg/dl) as well as on viral hepatitis with coma (21.89 �3 mg/dl).

P
Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. Sien-Sing Yang, Chao-Tien Hsu,

Ministero della Salute Italia
File Format: PDF/Adobe Acrobat Your browser may not have a PDF reader available. Google recommends visiting our Epidemilogic Surveillance of Acute Viral Heaptitis. SMR. Standard Mortality Rate. SIDRIA. Italian Study on Respiratory Diseases in Childhood

Hepatitis C Therapy - SciClone Reports Results from First ZADAXIN Phase 3 Hepatitis C Trial


SciClone Reports Results from First ZADAXIN Phase 3 Hepatitis C Trial
Pharma Live - SAN MATEO, Calif. -- December 14, 2005 -- SciClone Pharmaceuticals, Inc. ( with pegylated interferon alpha to treat patients with hepatitis C virus (HCV) who have failed previous interferon-based

Legal blow in fight for hepatitis C inquiry
PA News via The Scotsman Online - A judge refused to break Scottish legal ground by protecting relatives of three victims against expenses of about 10,000 each should their court action against the Executive fail. why hundreds of people contracted hepatitis C through contaminated blood transfusions in

SciClone stock falls on hepatitis drug data
AP via Seattle Post Intelligencer - trial data for the company's drug to treat hepatitis C liver disease showed no significant benefit to its said trial data for its hepatitis C treatment drug Zadaxin didn't show

SciClone says drug misses trial targets, shares plunge
Reuters - said its experimental drug Zadaxin to treat Hepatitis C infection did not show statistically significant results in

Hepatitis C Therapy - Hepatitis C: Early Detection Means Better Health(NC)-Experts estimate that 240,000

Hepatitis C: Early Detection Means Better Health

(NC)-Experts estimate that 240,000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus. The only way to find out for sure if you have hepatitis C is through a blood test. Your doctor can order one for you. By taking this action you'll be doing yourself a favour because hepatitis C can be treated only if it has been detected. Untreated hepatitis C can lead to severe conditions that require long-term, intensive care.

For more information visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.


Wednesday, December 14, 2005


Hepatitis C Therapy - Deaths from hepatitis C double


Deaths from hepatitis C double
Guardian Unlimited - Even people who tried drugs briefly 20 to 30 years ago are at risk of developing liver failure or cancer. December 14, 2005The Guardian Deaths related to hepatitis C infection in England have doubled in less than

Clinical Presentation and Course of Acute Hepatitis C Infection in HIV-Infected Patients
JAIDS - Health

Body Weight Correlates with Hepatocellular Cancer: Presented at AASLD
Doctors Guide - Previous studies have shown that obesity is a risk factor for hepatocellular carcinoma (HCC), he said in his presentation on November 13th. Dr. Body weight appears to influence the course of hepatitis C infection, with lower body weight being protective against

Hepatitis C Therapy - Hepatitis - Information / Diagnosis / Treatment / Prevention


Hepatitis - Information / Diagnosis / Treatment / Prevention
Gastroenterology & Hepatology Research Center: Viral Hepatitis C Johns Hopkins Medicine : Gastroenterology & Hepatology Research Center: Viral Hepatitis A&E Johns Hopkins Medicine : Hepatitis-C

Glucocorticosteroids for viral hepatitis C (Cochrane Review)
UK: John Wiley & Sons, Ltd. All rights reserved. Glucocorticosteroids for viral hepatitis C (Cochrane Review) Brok J, Mellerup MT, Krogsgaard K, Gluud C ABSTRACT What's new in

eMedicine - Hepatitis : Article by Adrienne M Buggs, MD, FACEP
Opin Emerg Drugs 2003 May; 8(1): 9-25 [Medline] . Poynard T, Yuen MF, Ratziu V, Lai CL: Viral hepatitis C. Lancet 2003 Dec 20; 362(9401): 2095-100 [Medline] . Public Health: Hepatitis A. CMAJ 1997 Feb 15

Management of Hepatitis C (CBM 97-1)
archived Skip to Content Archives Search NLM Web Site NLM Home | About the Archives Home > NLM Archives > Document content is not current. Links may be broken. Current Bibliographies in Medicine 97-1

The Hepatitis System
to child at birth, through sexual contact, blood transfusions, or needles. Viral Hepatitis C: The most common of viral forms, typically spread through blood transfusions

Hepatitis Central, Hepatitis C Virus Dynamics In Vivo: Effect of
Opolon P, Zarski JP. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. H EPATOLOGY 1996; 24: 778-789. Balart LA, Perrillo R

Tuesday, December 13, 2005


Hepatitis C Therapy - METRO Trial: Hepatitis C Information


METRO Trial: Hepatitis C Information
Another less common way for Hepatitis C infection to occur is through mother-to-child transmission, where mothers who have a Hepatitis C infection give the infection to their

Hepatitis C: Symptoms
The most common symptom of hepatitis C infection Signs relating to liver failure End stage liver failure You can have HCV and not know it. During the acute phase the disease is mild and many people do

Hepatitis C Virus Infection: BC HealthFile #40a
Most people feel well, have no symptoms and don't know they have hepatitis C infection. Some people may have a brief illness with symptoms usually appearing six to twelve weeks after being

Hospital Practice: Chronic Hepatitis C: Early Intervention
Chronic Hepatitis C: Early Intervention RAYMOND S. KOFF University of Massachusetts Chronic hepatitis C infection is the most common liver disease in the United States; it accounts for up to 12,000

Hepatitis C Therapy - - Cash blow for families in Hep C fight


- Cash blow for families in Hep C fight
Glasgow Evening Times - Families of Hepatitis C victims who received contaminated blood transfusions have suffered a setback in their fight for a public inquiry.

Hep C Woman Bit Man On Ear
Daily Record - UKLocalNews 23 November 2005 HEP C WOMAN BIT MAN ON EAR A DRUNK woman who knew she had hepatitis C bit a stranger's ear after he refused to dance with her.Fiona Manson's victim went through six

FDA Fast-Tracks Hep C Protease Inhibitor
POZ.com - Email to a friend FDA Fast-Tracks Hep C Protease Inhibitor by Staff December 8, 2005-The U.S.

Expert calls for jail needle exchange
ninemsn - show 34 per cent of prisoners have Hep C compared with 1 per cent of the general population.Hep C is a blood-borne virus

Hepatitis C Therapy - Viral Hepatitis C Integration Program (VHIP): Update for HIV Clinic Staff (PDF)


Viral Hepatitis C Integration Program (VHIP): Update for HIV Clinic Staff (PDF)
... Multnomah County Health Department. Viral Hepatitis C Integration Program ... The MCHD Viral Hepatitis C Integration Program (VHIP) is dedicated to building ...

Hepatitis C: Plan: Index | CDC Viral Hepatitis
National Hepatitis C Prevention Strategy. A Comprehensive Strategy for the Prevention and Control of. Hepatitis C Virus Infection and its Consequences. TABLE OF CONTENTS. Executive Summary

Hepatitis C
Hepatitis C. By Howard J. Worman, M. D. The Hepatitis C Virus (HCV) HCV was discovered in 1989 by investigators at Chiron, Inc. ... Evolving Treatments for Chronic Viral Hepatitis C. From Howard J ...

Hepatitis non-B, non-C - Test for Viral Hepatitis
REFERENCES - Tests for Viral Hepatitis. 1. ... Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update ...

Hepatitis C Therapy - Cirrhosis Of The Liver



Cirrhosis Of The Liver
Title: Cirrhosis Of The Liver
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 12/1/2005
Your Results May Vary For HCV Treatment
According to this study, actual treatment results may be only half as good as touted. Doctors tend to trust the numbers presented by the pharaceutical companies. The pharmaceutical companies have a vested interest in presenting the best numbers they can...
Ultrasound
Title: Ultrasound
Category: Procedures and Tests
Created: 12/31/1997
Last Editorial Review: 10/15/2005

Hepatitis C Therapy - Is Hepatitis C (HCV) Transmission Preventable?


Is Hepatitis C (HCV) Transmission Preventable?
... The hepatitis C virus (HCV) is the most common chronic blood-borne virus in the US and a ... Sexual transmission of HCV is very uncommon. About 4 million Americans are ...

HCV and Brain Dysfunction
HCV Found in Autopsy Brain Tissue- Emerging evidence of hepatitis C virus neuroinvasion. AIDS: Volume 19 Suppl 3 October 2005 p S140-S144 ... been reported that hepatitis C virus (HCV) infection is associated with cognitive dysfunction ... is also emerging evidence that HCV infection can have negative neurocognitive effects ...

Hepatitis C: The Test
Hepatitis C. The Test. How is it used? Each of the five most common tests has a slightly different purpose: Anti-HCV tests detect the presence of antibodies to the virus, indicating exposure to HCV.

About the Hawaii Center for Volcanology
... The Hawaii Center for Volcanology (HCV) was conceived and created in 1992 as a cooperative ... the primary organizations listed below. HCV is presently undergoing re-organization and ...

HCV Future Therapies
FUTURE HCV THERAPIES. INTRODUCTION: ... Challenges facing our current treatment of HCV include lack of efficacy in genotype I ... represent a majority of U.S. HCV infections), combination therapy's toxicity, the expense ...

Hepatitis C Therapy - Hepatitis B



Hepatitis B
Title: Hepatitis B
Category: Diseases and Conditions
Created: 1/26/2001 11:58:00 AM
Last Editorial Review: 9/21/2005
More HCV Treatment News Coverage
The Los Angeles Times is one of the largest daily newspapers in the U.S. Their interest in HCV is indicative of a growing awareness of the extent of the disease in this country. The article clearly focuses on the hope...

Monday, December 12, 2005


Hepatitis C Therapy - Pegasys combination therapy approved for hepatitis C and HIV co-infection treatment in Europe


Pegasys combination therapy approved for hepatitis C and HIV co-infection treatment in Europe
... Pegasys, the market leader worldwide in hepatitis C therapy, provides significant benefit over conventional combination ...

All About Hepatitis C - Glossary
Hepatitis C resources on hep C causes, symptoms, testing, and treatments. ... to detect genetic material from the hepatitis C virus for at least 24 weeks after hepatitis C therapy is completed ...

Best Practice of Medicine -Hepatitis C - Print Report
Best Practice of Medicine. Press Ctrl-P (PC) or -P (Mac) to print this page. Article URL: http://merck.micromedex.com/index.asp?page=bpm_brief&article_id=CPM02HP370. Hepatitis C

Hepatitis C Therapy & Depression
I have hepatitis C infection. But I'm afraid to start interferon therapy since I'm prone to depression. What should I do?

The Body: New Advances in Hepatitis C Therapy
New Advances in Hepatitis C Therapy, at The Body, the complete HIV/AIDS resource. ... New Advances in Hepatitis C Therapy. August, 2000. The major points from "Hepatitis C Therapy" ...

Hepatitis C Therapy - Viral hepatitis


Viral hepatitis
ivral hepatitis / vrial hepatitis / viarl hepatitis / virla hepatitis / vira lhepatitis / Viral ehpatitis / Viral hpeatitis / Viral heaptitis / Viral

[Immunohistochemical detection of hepatitis C virus antigen from
virus antigen from hepatocellular carcinoma] [Article in Chinese] Zhou F, Zhao L, Liu C, Lei X, Zhou S, Wang J. Institute of Viral Heaptitis, First Affiliated

Observation of lipid profile and lipoproteins in viral hepatitis
VLDL levels were significantly decreased in patients of viral heaptitis (22.13 �8 mg/dl) as well as on viral hepatitis with coma (21.89 �3 mg/dl).

Lamivudine does not increase the efficacy of interferon in the
hbv_research archives Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B.

[Immunohistochemical detection of hepatitis C virus antigen from
Institute of Viral Heaptitis, First Affiliated Hospital, WCUMS, Chengdu 610041. To investigate the infection of HCV and the expression of HCV antigen (HCAg)

ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis
Viral heaptitis, type B in experimental animals. Am J Med Sci 270:189-195. Bassett SE, Thomas D, Brasky, KM, Lanford RE. 1999. Viral persistence antibody to

Hepatitis C Therapy - [Behavior of Owren's Thrombotest in acute viral hepatitis, viral


[Behavior of Owren's Thrombotest in acute viral hepatitis, viral
[Behavior of Owren's Thrombotest in acute viral hepatitis, viral heaptitis of prolonged duration, acute post-hepatitis atrophy of the liver and its relation

[Immunohistochemical detection of hepatitis C virus antigen from
virus antigen from hepatocellular carcinoma] [Article in Chinese] Zhou F, Zhao L, Liu C, Lei X, Zhou S, Wang J. Institute of Viral Heaptitis, First Affiliated

Current Opinion in Organ Transplantation - Fulltext: Current
International Conference on Therapies for Viral Heaptitis 1999. [Context Link]. 89. Ameer B: Acetaminophen hepatotoxicity augmented by zidovudine.

Lamivudine does not increase the efficacy of interferon in the
the treatment of mutant type chronic viral heaptitis B. Sien-Sing Yang, Chao-Tien Hsu, Jui-Ting Hu, Yung-Chih Lai, Chi-Hwa Wu. Sien-Sing Yang, Jui-Ting Hu,

Hepatitis C Therapy - A Summary of Chronic Hepatitis C InfectionHepatitis C is a

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.

Hepatitis C Therapy - AMPLICOR HCV MONITOR Test/COBAS AMPLICOR HCV MONITOR Test Product


AMPLICOR HCV MONITOR Test/COBAS AMPLICOR HCV MONITOR Test Product
Roche Diagnostics Products and Services Product Sheet for AMPLICOR HCV MONITOR Test and COBAS AMPLICOR HCV MONITOR Test Back to Key Products HCV Testing AMPLICOR HCV

the ABC's of Hepatitis - Hepatitis Foundation International (Worldwide
HCV Infection There is NO vaccine to prevent HCV.Vaccines for Hepatitis A and B do not provide immunity against hepatitis C. There are various genotypes of HCV and

HCV Hepatitis C Anonymous - 12 Steps - Home Page - Hep C Virus - 12
HCV Hepatitis Anonymous supplies current hepatitis news & information on Hepatitis C (HCV), 12 steps, big book, positive attitudes, online HCV meetings and live chat!! about us

euHCVdb : The European HCV Database Home Page
To acces the European HCV database (euHCVdb), you need a browser with frame support Please upgrade your browser

Viropharma Incorporated | Therapeutic Focus | HCV-796
virus (HCV). Together with Wyeth, ViroPharma has discovered multiple, chemically distinct compound series that target the RNA replication process (RNA Polymerase) of HCV. The current focus of the

Sex and HCV
with HCV-positive partners were 3.7 times more likely to have HCV than females with HCV-negative partners; this pattern was not evident in males. The titer of HCV RNA and HCV

Hepatitis C Therapy - Treatment Recommendations for Patients with Chronic Hepatitis C


Treatment Recommendations for Patients with Chronic Hepatitis C
These guidelines cover the management, assessment, and treatment of veterans with hepatitis C in the VA system.

Hepatitis C (infectious liver inflammation type C)
Hepatitis is the Latin word for liver inflammation. Type C hepatitis is caused by a virus called hepatitis C virus. It was previously referred to as

Hepatitis C: Index | CDC Viral Hepatitis
Living with Chronic Hepatitis C. English Language version Abobe; Spanish Language version Abobe; Russian Language version Abobe. Hepatitis C Prevention

Chronic Hepatitis C: Current Disease Management
Explains the causes and symptoms of hepatitis C, along with information about diagnosis and treatment.

New and Future Treatments for Chronic Hepatitis C
Treatment of chronic hepatitis C is presently based on the use of Virtually all of the serious complications of chronic hepatitis C result from

Sunday, December 11, 2005


Hepatitis C Therapy - Alternative Hope For Hep C


Alternative Hope For Hep C
includes personal account of living with Hepatitis C.

Hepatitis C Dating at Hep C Singles Online
... Hep-C Singles Online is the original and largest dating website for singles with Hepatitis-C found on ... that special someone if you have Hep-C. We have made it ...

Hep-C ALERT Major Supporters
... HEP-C ALERT. Hepatitis & HIV: From the Streets to the Specialist ... Hep-C ALERT has many sources of financial support, including personal donations, fee-for-service contracts ...

Hepatitis C
Background. For a very long time, this hepatitis had no identity except as non-A, non-B hepatitis. It was a diagnosis of exclusion. In 1989, the hepatitis C virus was discovered.

National Hepatitis C Advocacy Council, - Main Index
The National Hepatitis C Advocacy Council has been formed in an effort to bring together the collective strengths of hepatitis C patient advocacy organizations.

Hep Helper
daily regimen of vitamins and organic herbs to manage Hepatitis C.

Hepatitis C Therapy - ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis


ILAR Journal Online, Volume 42(2) 2001: Animal Models of Hepatitis
Barker, LF, Maynard JE, Purcell RH, Hoofnagle JH, Berquist KR, London WT. 1975. Viral heaptitis, type B in experimental animals. Am J Med Sci 270:189-195. Bassett SE, Thomas D, Brasky, KM, Lanford RE

World J Gastroenterol
does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. Yang SS, Hsu CT, Hu JT, Lai YC, Wu CH. World J Gastroenterol 8(5):868-871 Mutational

World J Gastroenterol
the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. World J Gastroenterol 2002; 8: 868-871 12 Terrault NA. Combined interferon and

USDA Funded Projects
diseases such as postweaning multisystemic wasting syndrome and Michigan rabbit viral heaptitis. E) Determine the effects of sample handling on laboratory tests for bovine tuberculosis. The

Hepatitis C Therapy - Non-invasive markers of liver damage effective in HIV / hepatitis C co-infected patients


Non-invasive markers of liver damage effective in HIV / hepatitis C co-infected patients
Aidsmap - Markers of liver damage due to hepatitis C infection that can be measured from blood samples are as effective in

Clinical Presentation and Course of Acute Hepatitis C Infection in HIV-Infected Patients
JAIDS - Health

Ciphergen and University of Texas Medical Branch at Galveston Sign Collaboration Agreement in Liver Disease
PR Newswire - Professor of Internal Medicine atUTMB, have been studying how Hepatitis C infection can damage or destroy theliver

Hepatitis C Therapy - HEPATITIS C FACT SHEET (PDF)


HEPATITIS C FACT SHEET (PDF)
... Chin J, ed. Viral Hepatitis C. In: Control of ...

VIRAL HEPATITIS C
VIRAL HEPATITIS C - FREQUENTLY ASKED QUESTIONS. 1. What is hepatitis C? Hepatitis C is a liver disease caused by the hepatitis C virus (HCV), which is found in the blood of persons who have this disease.

CDC - Viral Hepatitis C
Hepatitis C is a disease of the liver caused by the hepatitis C virus. You may be at risk for hepatitis C and should contact your medical care provider for a blood test if you:

Genotypes in patients with viral hepatitis C
Genotypes in patients with viral hepatitis C Genotypes in patients with viral hepatitis C Hepatitis C virus (HCV) is a small single stranded RNA virus, that belongs to the Flaviviridae family. HCV can be classified into six major genotypes and ...

http://www.mchealth.org/pha/teams2002/hepc_update.doc (MICROSOFT WORD)
... Multnomah County Health Department. Viral Hepatitis C Integration Program ... The MCHD Viral Hepatitis C Integration Program (VHIP) is dedicated to building capacity within MCHD and in ...

Hepatitis C: Plan: References | CDC Viral Hepatitis
TABLE OF CONTENTS. National Hepatitis C Prevention Strategy. References

Hepatitis C Therapy - Hepatitis C


Hepatitis C
... In: Shikata T, Purcell RH, Uchida T, eds. Viral Hepatitis C, D, and E ... In: Shikata T, Purcell RH, Uchida, eds. Viral Hepatitis C, D, and E ...

Hepatitis C: The Forum: The Issues: Ann Jesse's Testimony
... Are you aware that viral hepatitis C is an equal opportunity infector that has the potential of wreaking ... is of the essence as viral hepatitis C threatens more and more ...

Genotypes in patients with viral hepatitis C
Genotypes in patients with viral hepatitis C Genotypes in patients with viral hepatitis C Hepatitis C virus (HCV) is a small single stranded RNA virus, that belongs to the Flaviviridae family. HCV can be classified into six major genotypes and ...

WebMD: Hepatitis C Topic Overview
... Hepatitis C,viral hepatitis C,infection,infectious disease,Chronic hepatitis,treatment,medical treatment,virus,viruses ...

Hepatitis, Viral
Maryland Medical Center Programs. Hepatitis, Viral. Hepatitis is a serious disorder in which liver cells become inflamed. The inflammation is most occurs because of a virus. ... Management of viral hepatitis C. J Gastroenterol Hepatol. 2002;17 Suppl: S146-S154 ...

The Body: Hepatitis C Reference Manual
Hepatitis C Reference Manual, at The Body, the complete HIV/AIDS resource. ... Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration ...